Sacha.characteristics and Requirements for Large Volume Parenterals

Embed Size (px)

Citation preview

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    1/20

    Presenter

    Characteristics and Requirements for

    Large Volume Parenterals (LVPs)USP Workshop on Thresholds andBest Practices for Parenteral and

    Ophthalmic Drug Products

    Bethesda, MD

    February 22 and 23, 2011

    Gregory A. Sacha, Ph.D.

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    2/20

    Large Volume Intravenous Solution 2

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    A single-dose injection that is intended forintravenous use and is packaged in containerslabeled as containing more than 100 mL.

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    3/20

    Characteristics of LVPs 3

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Packaged in glass bottles or in large volume flexiblecontainers.

    May contain greater than 100 ml to greater than 1 or 2 L

    Sterile

    Pyrogen-Free

    Essentially free of particulate matter

    No anti-microbial agentsIsotonicity

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    4/20

    Types of Large Volume Intravenous Solutions 4

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Electrolytes

    CarbohydratesNutritional Solutions

    Proteins

    Lipid Emulsions

    Peritoneal Dialysis

    Irrigating Solutions

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    5/20

    Route of Administration 5

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Intravenous

    Direct Injection

    Infusion

    Subcutaneous

    Intramuscular

    Intradermal

    Intraspinal

    Intrathecal

    Intra-arterial

    Others

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    6/20

    Methods of Delivery for LVPs 6

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Peripheral Vein if solution with low osmolality

    Hyper or hypotonicity can irritate the vein - phlebitis

    Central Vein Subclavian Vein

    A B

    A. From http://www.hsc.wvu.edu/mbrcc/bmt/siteImages/centralVenousCatheter.jpg

    B. From http://www.nursinghomesabuseblog.com/uploads/image/picc.png

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    7/20

    Methods of Delivery for LVPs 7

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Peritoneal Dialysis

    Dialysis membrane assisted hemodialysis

    Continuous ambulatory dialysis

    Patient warms solution to body temperature

    Injects into abdominal cavity

    Exchanges solution 4 to 5 times daily

    A. From http://www.wirralchesterkidney.nhs.uk/images/principle.jpgA

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    8/20

    Preparation and Hospital Practice 8

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Ready to use solutions stored on nursing units foreasy access. Saline and Dextrose solutions.

    Medications can be added to the large volumecontainers in the pharmacy.

    Prepared when ordered or in batches every 8 to 12

    hours, labeled, and delivered to the nursing unit. Typically expire after 24 hours

    Some drugs prepared in LVPs as ready to use

    Propofol

    Ciprofloxacin

    Lidocaine HCl

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    9/20

    Preparation of Parenteral Nutrition Formulations 9

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Custom formulation designed for each patient in US

    Use Automix and Micromix compounders to transferquantities of each additive to sterile, empty Viaflexcontainers.

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    10/20

    Materials of Construction 10

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Basic Types of Plastics

    Thermoplastics

    Polymers that soften upon heating and solidify uponcooling

    Most parenteral packaging

    Thermosets Chemically reactive polymers in the fluid state

    Harden irreversibly by cross-linking

    Epoxies, melamine resins, cross-linked polyestersand phenolics

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    11/20

    Most Common Polymers for Sterile Products 11

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Polyethylene (PE)

    Polyvinylchloride (PVC)Polypropylene (PP)

    Polyamide (Nylon)

    Polycarbonate (PC)

    Ethylene vinyl acetate (EVA)

    Polyolefin (mixtures of low density PE, high densityPE, PP, and EVA)

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    12/20

    Large Volume Flexible Containers 12

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Advantages

    Durable and light weight No air interchange. The bag collapses as it empties.

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    13/20

    Large Volume Flexible Containers 13

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Disadvantages

    Permeation of vapors and other molecules in eitherdirection through the walls.

    Resolved by overwrapping the containers.

    Leaching of constituents from the plastic into the product.

    Plasticizers and anti-oxidants Sorption of drug molecules or ions on the plastic material.

    Proteins, warfarin sodium, diazepam

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    14/20

    Types of Flexible Containers 14

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    PVC polyvinylchloride was the first polymer used forcollapsible containers.

    Performs best with respect to collapsibility andtransparency

    May leach DEHP (di (2-ethyl hexyl) phthalate

    Banned by countries such as Germany, Sweden,France, Canada, and others.

    Produces dioxin when incinerated

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    15/20

    Types of Flexible Containers 15

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Ethylene vinyl acetate films (EVA)

    Developed to improve compatibility and moisture

    permeation characteristics However, moisture permeation is poor and film

    requires overwrap

    Combinations Multilayer films developed to reduce moisture

    permeation

    Ethylene vinyl alcohol can be used as core film for itshigh gas barrier properties.

    Physically bonded between two layers of EVA

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    16/20

    Comparative Properties of Polymers 16

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    17/20

    Sterilization of Flexible Containers 17

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Thermal Sterilization

    Many plastics will soften or melt.

    Ethylene Oxide (EtO) May be used for the empty container and then aseptically

    filled.

    Must evaluate possible residues and degradants fromEtO.

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    18/20

    Sterilization of Flexible Containers 18

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Gamma Radiation

    May affect the appearance of the plastic and the

    stability of the product

    PVC can change color from clear to yellow, possiblepH shifts, increases in extractables

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    19/20

    Possible Extractables 19

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Plastics Antioxidants: BHT, thioesters, phosphates

    Lubricants: silicones, polyethylene waxes

    Plasticizers: phthalates

    Glass

    Major extractables: silicon and sodium Minor extractables: K, Ca, Ba, Al

    Trace extractables: Fe, Mg, Zn

    Dependant upon pH, buffer, and other components informulation

  • 8/3/2019 Sacha.characteristics and Requirements for Large Volume Parenterals

    20/20

    Summary 20

    2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

    Contain >100 mL, no antimicrobial agents

    Typically simple solutions NaCl, Dextrose, other nutritional solutions

    Available in glass and flexible containers

    Trend toward multi-chamber bags

    Available for infusions, dialysis, irrigation

    Plastic films chosen based on flexibility, resistance tomoisture permeation, ability to sterilize